You can find the annual or quarterly income statement of Vor Biopharma Inc here for insights into the performance and operational efficiency of Vor Biopharma Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

Operating expenses

-1.42%28.11M

844.67%274.28M

2.99%33.29M

11.33%31.31M

-19.26%28.51M

-9.76%29.04M

6.26%32.33M

13.75%28.12M

46.53%35.32M

47.64%32.17M

33.43%30.42M

35.07%24.73M

29.56%24.10M

18.56%21.79M

66.06%22.80M

16.87%18.31M

57.84%18.60M

128.61%18.38M

74.28%13.73M

298.75%15.66M

217.14%11.79M

--8.04M

--7.88M

--3.93M

--3.72M

R&D expenses

-35.18%14.14M

1098.27%261.50M

9.78%26.70M

21.30%25.35M

-20.97%21.82M

-8.68%21.82M

10.98%24.32M

22.48%20.90M

63.59%27.61M

55.85%23.90M

43.42%21.91M

34.42%17.06M

30.56%16.88M

18.22%15.33M

70.90%15.28M

12.03%12.69M

58.74%12.93M

117.07%12.97M

44.89%8.94M

282.25%11.33M

419.26%8.14M

--5.97M

--6.17M

--2.96M

--1.57M

Depreciation, depletion, and amortization

-99.78%2.00K

133.33%2.10M

-12.51%825.00K

188.89%2.60M

0.00%900.00K

12.66%943.00K

42.41%900.00K

0.00%900.00K

56.52%900.00K

96.48%837.00K

58.00%632.00K

140.64%900.00K

43.75%575.00K

36.98%426.00K

65.29%400.00K

94.79%374.00K

280.95%400.00K

371.21%311.00K

490.24%242.00K

500.00%192.00K

--105.00K

--66.00K

--41.00K

--32.00K

Operating profit

1.42%-28.11M

-844.67%-274.28M

-2.99%-33.29M

-11.33%-31.31M

19.26%-28.51M

9.76%-29.04M

-6.26%-32.33M

-13.75%-28.12M

-46.53%-35.32M

-47.64%-32.17M

-33.43%-30.42M

-35.07%-24.73M

-29.56%-24.10M

-18.56%-21.79M

-66.06%-22.80M

-16.87%-18.31M

-57.84%-18.60M

-128.61%-18.38M

-74.28%-13.73M

-298.75%-15.66M

-217.14%-11.79M

---8.04M

---7.88M

---3.93M

---3.72M

Net non-operating interest income (expenses)

Non-operating interest income

81.45%1.73M

-55.10%537.00K

-47.11%805.00K

-67.85%599.00K

-55.13%954.00K

-45.51%1.20M

-23.48%1.52M

128.59%1.86M

579.23%2.13M

1550.38%2.19M

3057.14%1.99M

1409.26%815.00K

552.08%313.00K

1230.00%133.00K

800.00%63.00K

--54.00K

--48.00K

--10.00K

-75.86%7.00K

-100.00%0.00

--0.00

--29.00K

--35.00K

--77.00K

Non-operating interest expense

----

--0.00

----

--0.00

Special income (expenses)

---790.46M

---1.30B

----

--0.00

----

--0.00

Other non-operating income (expenses)

--4.15M

----

Income before tax

-2848.89%-812.68M

-5552.75%-1.57B

-5.46%-32.49M

-16.95%-30.71M

16.97%-27.56M

7.14%-27.84M

-8.34%-30.80M

-9.83%-26.26M

-39.52%-33.19M

-38.41%-29.98M

-25.05%-28.43M

-31.00%-23.91M

-28.21%-23.79M

-17.90%-21.66M

-65.69%-22.74M

-16.53%-18.25M

-57.44%-18.55M

-128.48%-18.37M

-74.84%-13.72M

-302.34%-15.66M

-223.85%-11.79M

---8.04M

---7.85M

---3.89M

---3.64M

Income after tax

-2848.89%-812.68M

-5552.75%-1.57B

-5.46%-32.49M

-16.95%-30.71M

16.97%-27.56M

7.14%-27.84M

-8.34%-30.80M

-9.83%-26.26M

-39.52%-33.19M

-38.41%-29.98M

-25.05%-28.43M

-31.00%-23.91M

-28.21%-23.79M

-17.90%-21.66M

-65.69%-22.74M

-16.53%-18.25M

-57.44%-18.55M

-128.48%-18.37M

-74.84%-13.72M

-302.34%-15.66M

-223.85%-11.79M

---8.04M

---7.85M

---3.89M

---3.64M

Net income from continuous operations

-2848.89%-812.68M

-5552.75%-1.57B

-5.46%-32.49M

-16.95%-30.71M

16.97%-27.56M

7.14%-27.84M

-8.34%-30.80M

-9.83%-26.26M

-39.52%-33.19M

-38.41%-29.98M

-25.05%-28.43M

-31.00%-23.91M

-28.21%-23.79M

-17.90%-21.66M

-65.69%-22.74M

-16.53%-18.25M

-57.44%-18.55M

-128.48%-18.37M

-74.84%-13.72M

-302.34%-15.66M

-223.85%-11.79M

---8.04M

---7.85M

---3.89M

---3.64M

Net income attributable to controlling interests

-2848.89%-812.68M

-5552.75%-1.57B

-5.46%-32.49M

-16.95%-30.71M

16.97%-27.56M

7.14%-27.84M

-8.34%-30.80M

-9.83%-26.26M

-39.52%-33.19M

-38.41%-29.98M

-25.05%-28.43M

-31.00%-23.91M

-28.21%-23.79M

-17.90%-21.66M

-52.08%-22.74M

-2.35%-18.25M

-32.81%-18.55M

-106.52%-18.37M

-74.58%-14.95M

-305.39%-17.83M

-236.95%-13.97M

---8.89M

---8.56M

---4.40M

---4.15M

Net income attributable to common shareholders

-2848.89%-812.68M

-5552.75%-1.57B

-5.46%-32.49M

-16.95%-30.71M

16.97%-27.56M

7.14%-27.84M

-8.34%-30.80M

-9.83%-26.26M

-39.52%-33.19M

-38.41%-29.98M

-25.05%-28.43M

-31.00%-23.91M

-28.21%-23.79M

-17.90%-21.66M

-52.08%-22.74M

-2.35%-18.25M

-32.81%-18.55M

-106.52%-18.37M

-74.58%-14.95M

-305.39%-17.83M

-236.95%-13.97M

---8.89M

---8.56M

---4.40M

---4.15M

Basic earnings per share

-30116.29%-121.63

-61539.21%-251.24

42.52%-0.26

-13.31%-0.44

18.01%-0.40

8.86%-0.41

-5.53%-0.45

26.41%-0.39

21.56%-0.49

22.70%-0.45

29.62%-0.43

-8.15%-0.53

-24.58%-0.63

-16.17%-0.58

-49.94%-0.61

2.79%-0.49

-28.18%-0.50

-99.58%-0.50

-69.24%-0.41

-305.38%-0.50

-236.95%-0.39

---0.25

---0.24

---0.12

Diluted earnings per share

-30116.29%-121.63

-61539.21%-251.24

42.52%-0.26

-13.31%-0.44

18.01%-0.40

8.86%-0.41

-5.53%-0.45

26.41%-0.39

21.56%-0.49

22.70%-0.45

29.62%-0.43

-8.15%-0.53

-24.58%-0.63

-16.17%-0.58

-49.94%-0.61

2.79%-0.49

-28.18%-0.50

-99.58%-0.50

-69.24%-0.41

-305.38%-0.50

-236.95%-0.39

---0.25

---0.24

---0.12

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

